Next generation sequencing market size, Key Players, worldwide forecast to 2027
- celina redden
- Sep 20, 2021
- 2 min read
Next Generation Sequencing Market Research Report: By Technology (Targeted Sequencing & Resequencing, Whole Genome Sequencing and Whole Exome Sequencing), Workflow (Pre-Sequencing, Sequencing, and Data Analysis), Application (Oncology, Clinical Investigation, Reproductive Health, Human Leukocyte Antigen Typing or Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, Consumer Genomics), End User (Hospitals & Clinics, Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027
Next Generation Sequencing Market Analysis
Next Generation Sequencing Market Size is expected to exhibit significant growth over the forecast period. The NGS Market Growth is projected to register a CAGR of 18.05% over the forecast period to reach USD 20,347.45 Million by 2025.
Market Segmentation
The Global Next-Generation Sequencing Market has been segmented into Technology, Workflow, Application, End User, and Region.
Based on technology, the global next-generation sequencing market has been divided into targeted sequencing & resequencing, whole-genome sequencing, and whole-exome sequencing.
Based on workflow, the global next-generation sequencing market has been divided into pre-sequencing, sequencing, and data analysis.
The global next-generation sequencing market, by applications, has been segmented into oncology, clinical investigation, reproductive health, human leukocyte antigen typing or immune system monitoring, metagenomics, epidemiology, and drug development, agrigenomics & forensics, consumer genomics, and others.
The global next-generation sequencing market, by end-user, has been segmented into hospitals & clinics, diagnostic laboratories, pharmaceutical and biotechnology companies, and others.
Competitive Landscape
Agilent Technologies, Inc. (US), Eurofins Scientific (Luxembourg), Genome Life Sciences (India), GenScript (US), Illumina, Inc. (US), Thermo Fisher Scientific (US), Qiagen (Germany), PerkinElmer Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Pacific Biosciences of California, Inc. (US), Xcelris Genomics (India), Macrogen, Inc. (South Korea), BGI (US), Charles River (US), and Oxford Nanopore Technologies (UK) are some of the key players operating in the global next generation sequencing market.
Key Market Opportunities
Favorable funding scenario and immense support for scientific research would augment the next-generation sequencing
Key Market Drivers
Rising technological advancements, increasing applications of NGS, and growth in genome mapping programs. Increasing demand for personalized medicine and high growth in the development of companion diagnostics
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Comments